Showing results (1461-1470 of 1,876) with videos related to
Sort By:
Pageof 188
Open Heart|January 12, 2022
Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary interventionAndrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, et al.Open Heart|January 21, 2022
Prospective arrhythmia surveillance after a COVID-19 diagnosisThomas A Dewland, Isaac R Whitman, Sithu Win, et al.Open Heart|November 26, 2021
Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assayDennis Sandeman, Maaz B J Syed, Dorien M Kimenai, et al.Open Heart|December 31, 2021
Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) studyVictor W Zwartkruis, Bastiaan Geelhoed, Navin Suthahar, et al.Open Heart|March 25, 2021
Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panelChristopher F Spurney, Deborah Ascheim, Lawrence Charnas, et al.Open Heart|October 21, 2022
Percutaneous left atrial appendage occlusion discrepancy between randomised trials and clinical practiceThomas Kümler, Jarl Emanuel Strange, Niels Holmark AndersenOpen Heart|October 13, 2022
Novel scoring system based on clinical examination for prediction of in-hospital mortality in acute coronary syndrome patients: a retrospective cohort studyMiftah Pramudyo, Transiska Liesmadona Bijaksana, Achmad Fauzi Yahya, et al.Open Heart|September 23, 2022
Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisationRichard G Jung, Omar Abdel-Razek, Pietro Di Santo, et al.Open Heart|January 6, 2022
Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVISebastian Ludwig, Alina Goßling, Moritz Seiffert, et al.Open Heart|January 7, 2022
Colchicine for symptomatic coronary artery disease after percutaneous coronary interventionKah Long Aw, Amanda Koh, Han Lin Lee, et al.Pageof 188